Cargando…
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
Pulmonary embolism (PE) studies used direct oral anticoagulants (DOACs) with or without initial heparin. We aimed to (1) evaluate if PE patients benefit from initial heparin; (2) describe patient characteristics in the DOAC studies; and (3) investigate whether the anatomical extent of PE correlates...
Autores principales: | Brekelmans, Marjolein P. A., Büller, Harry R., Mercuri, Michele F., Ageno, Walter, Chen, Cathy Z., Cohen, Alexander T., van Es, Nick, Grosso, Michael A., Medina, Andria P., Raskob, Gary, Segers, Annelise, Vanassche, Thomas, Verhamme, Peter, Wells, Philip S., Zhang, George, Weitz, Jeffrey I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524852/ https://www.ncbi.nlm.nih.gov/pubmed/31249922 http://dx.doi.org/10.1055/s-0037-1615251 |
Ejemplares similares
-
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
por: Medina, Andria, et al.
Publicado: (2017) -
Rivaroxaban for the Treatment of Pulmonary Embolism
por: Vanassche, Thomas, et al.
Publicado: (2013) -
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
por: Bosch, Floris T. M., et al.
Publicado: (2021) -
Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants
por: Geldhof, Vincent, et al.
Publicado: (2014) -
Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required?
por: Weitz, Jeffrey I., et al.
Publicado: (2020)